Back
Schwab US Mid-Cap ETF Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Sell
47
SCHM
Schwab US Mid-Cap ETF
Last Price:
$30.37
Seasonality Move:
2.58%
Sell
45
LYEL
Lyell Immunopharma, Inc.
Last Price:
$31.56
Seasonality Move:
-22.7%
Sell
47
Schwab US Mid-Cap ETF (SCHM)
is a Sell
Is Schwab US Mid-Cap ETF a Buy, Sell or Hold?
-
The current Schwab US Mid-Cap ETF [SCHM] share price is $30.38. The Score for SCHM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
SCHM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Lyell Immunopharma, Inc. (LYEL)
is a Sell
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $31.59. The Score for LYEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
LYEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SCHM Stock Price Chart
What is Schwab US Mid-Cap ETF's stock price today?
-
The Schwab US Mid-Cap ETF share price today is $30.38Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SCHM is experiencing selling pressure, which indicates risk of future bearish movement.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $31.59The current trend is moderately bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
SCHM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.46 | Buy |
| Relative Strength Index (14 RSI): | 53.72 | Buy |
| Chaikin Money Flow: | -660980 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.75 - 30.61) | Buy |
| Bollinger Bands (100): | (29.1 - 30.2) | Buy |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.61 | Buy |
| Relative Strength Index (14 RSI): | 54.3 | Buy |
| Chaikin Money Flow: | -97541 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.36 - 35.26) | Buy |
| Bollinger Bands (100): | (10.99 - 25.97) | Buy |
SCHM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.45 | Sell |
| 20-day SMA: | 30.33 | Buy |
| 50-day SMA: | 29.81 | Buy |
| 200-day SMA: | 28.33 | Buy |
| 8-day EMA: | 26.41 | Buy |
| 20-day EMA: | 16.79 | Buy |
| 50-day EMA: | 8.34 | Buy |
| 200-day EMA: | 2.34 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.22 | Sell |
| 20-day SMA: | 31.47 | Buy |
| 50-day SMA: | 23.56 | Buy |
| 200-day SMA: | 14.09 | Buy |
| 8-day EMA: | 34.44 | Sell |
| 20-day EMA: | 31.53 | Buy |
| 50-day EMA: | 25.65 | Buy |
| 200-day EMA: | 18.32 | Buy |
Schwab US Mid-Cap ETF Earnings Growth & SCHM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.96 per share, and a decrease next year of $0.00 per share.
Schwab US Mid-Cap ETF Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||